PLEASANTON, Calif., Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...

Venture capital thrives on identifying and backing the next wave of transformative industries. For Limited Partners (LPs), ...

A Wednesday night earnings report left big questions about how the spending reductions would affect the company.

TD Cowen analyst Dan Brennan lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps a Hold rating on the shares. The ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Wednesday reported a loss of $49 million in its fourth quarter. The Pleasanton, California-based company said it had a ...

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for.

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of ...

The European single cell multiomics market, valued at $527.9 million in 2021, is poised for significant growth, with projections indicating an annual growth rate of 18.0% over the decade from 2021 to ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 36 tables and 76 figures, this 149-page report Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...